Effects of weight loss on metabolic syndrome in severely obese men without diabetes
Abstract
Introduction: Obesity is a chronic metabolic disease, characterized by an increased accumulation of fat in adipose tissue, to the extent that damages health and leads to the development of numerous complications. The increasing distribution of obesity has caused a large increase in the incidence of metabolic syndrome. Metabolic syndrome comprises a set of related risk factors for cardiovascular diseases and type 2 diabetes. The basis of therapeutic modalities of obesity make diet, exercise and lifestyle changes.
The aim: To assess the effect of reduction of body weight, performed by therapeutic lifestyle intervention, in the sample of extremely obese men without diabetes, on components of the metabolic syndrome and metabolic syndrome itself.
Material and Methods: Prospective study included 38 extremely obese men (mean age 41.68 ± 11.93 years, mean weight 142.08 ± 20.11kg, mean BMI 45.90 ± 5.65kg / m2). Anthropometric parameters and blood samples for biochemical analysis were measured before and after the reduction of body weight using therapeutic program, which included a very low calorie diet (VLCD) and low calorie diet (LCD) with physical activity. The relationship between variables was tested by Student’s t-test and Wilcoxon’s rank-sum test.
Results: Highly statistically significant reduction was found in waist circumference, systolic and diastolic blood pressure and triglyceride levels (p<0.001), while increased HDL and reduced fasting glucose levels were statistically significant (p<0.05). Before the diet, 63% of the extremely obese subjects had a diagnosis of the metabolic syndrome, while after the reduction of the body weight by conventional manner, the percentage of subjects with metabolic syndrome was 18% (p<0.001).
Conclusion: Weight loss after comprehensive lifestyle management in extremely obese men without diabetes improves all parameters of the metabolic syndrome and metabolic syndrome itself.
Keywords: metabolic syndrome, body weight, dietary regime
References
Rang HP, Dale MM, Ritter JM, Moore PK. Farmakologija. Beograd: Data status; 2005.
WHO: Obesity:Preventing and managing the global epidemic. Report of WHO consultation. WHO Technical Report Series 894, Geneva 2000, 5-15.
Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al. Harrison's principles of internal medicine 17th edition. New York: Mc Graw Hill Medical; 2008.
Blaha MJ, Tota-Maharaj R. Metabolic Syndrome : From Risk Factors to Management, 1st ed. Torino : SEED [Schlumberger Excellence in Educational Development] 2012.
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al; International Diabetes Federation Task Force on Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.
Rippe JM. Encyclopedia of Lifestyle Medicine and Health. Thousand Oaks, Calif : SAGE Publications, Inc. 2012
Matarese LE, Pories WJ. Adult weight loss diets: metabolic effects and outcomes. Nutr Clin Pract. 2014;29(6):759-67.
Tsai AG, Wadden TA. The evolution of very low calorie diets: an update and meta-analysis. Obesity (SilverSpring). 2006;14(8):1283-93.
Purnell JQ. Obesity: Calories or content: what is the best weight-loss diet? Nar Rev Endocrinol. 2009;5(8):419-20.
Anderson JW, Grant L, Gotthelf L, Stifler LT. Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program. Int J Obes (Lond). 2007;31(3):488-93.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878-84.
Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49(6):M252-7.
Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56(2):320-8.
Gotto AM Jr. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J. 2002;144(6 Suppl):S33-42.
Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-6
Bo S, Ciccone G, Baldi C, Benini L, Dusio F, Forastiere G, et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med. 2007;22(12):1695-703